Sign in

CIK 0001070494

  • Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061376651
Phone
+1 858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Planned sale Principal Accounting Officer sold 2,000 shares at $28.30 ($56,600)
  2. 4 Gift Director gave 2,918 shares (gift)
  3. 4 Open-market sale EVP, COO, Head of Commercial sold 4,960 shares at $22.64 ($112,294)
  4. 4 Open-market sale EVP, Chief Financial Officer sold 5,108 shares at $22.64 ($115,645)
  5. 4 Open-market sale Principal Accounting Officer sold 1,985 shares at $22.64 ($44,940)
  6. 4 Option exercise Director acquired 4,381 shares (option exercise)
  7. 4 Open-market sale EVP,General Counsel, Secretary sold 16,369 shares at $21.96 ($359,463)
  8. 4 Open-market sale CEO sold 51,563 shares at $21.96 ($1,132,323)
  9. 4 Planned sale Principal Accounting Officer sold 2,000 shares at $25.88 ($51,760)
  10. 4 Planned sale EVP, Chief Financial Officer sold 10,000 shares at $29.00 ($289,970)
  11. 4 Planned sale CEO sold 100,000 shares at $30.04 ($3,004,350)
  12. 4 Planned sale CEO sold 71,602 shares at an average $25.04 ($1,792,899)
  13. 4 Planned sale Principal Accounting Officer sold 2,000 shares at $24.15 ($48,300)
  14. 4 Planned sale Director sold 4,500 shares at $24.87 ($111,906)
  15. 4 Open-market sale EVP, Chief Financial Officer sold 974 shares at $25.02 ($24,369)
  16. 4 Option exercise Director acquired 18,002 shares (option exercise)
  17. 4 Derivatives Options or other derivatives
  18. 4 Option exercise Director acquired 18,002 shares (option exercise)
  19. 4 Option exercise Director acquired 18,002 shares (option exercise)
  20. 4 Option exercise Director acquired 18,002 shares (option exercise)

Page 6 of 35 · 686 filings